These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 36297228)

  • 21. Molecular mechanisms of
    Nakayama M; Ohara N
    Jpn Dent Sci Rev; 2017 Nov; 53(4):134-140. PubMed ID: 29201258
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of gingipains in the pathogenesis of periodontal disease.
    Imamura T
    J Periodontol; 2003 Jan; 74(1):111-8. PubMed ID: 12593605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency of Porphyromonas gingivalis fimA in smokers and nonsmokers after periodontal therapy.
    Abreu MGL; Kawamoto D; Mayer MPA; Pascoal VDB; Caiaffa KS; Zuza EP; Duque C; Camargo GADCG
    J Appl Oral Sci; 2019; 27():e20180205. PubMed ID: 30994772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are
    Singhrao SK; Olsen I
    J Alzheimers Dis Rep; 2018 Dec; 2(1):219-228. PubMed ID: 30599043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterogenic virulence and related factors among clinical isolates of Porphyromonas gingivalis with type II fimbriae.
    Inaba H; Nakano K; Kato T; Nomura R; Kawai S; Kuboniwa M; Ishihara K; Ooshima T; Amano A
    Oral Microbiol Immunol; 2008 Feb; 23(1):29-35. PubMed ID: 18173795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The sialidase inhibitor, DANA, reduces Porphyromonas gingivalis pathogenicity and exerts anti-inflammatory effects: An in vitro and in vivo experiment.
    Yu S; Fan X; Zheng S; Lin L; Liu J; Pan Y; Li C
    J Periodontol; 2021 Feb; 92(2):286-297. PubMed ID: 32609876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual lifestyle of Porphyromonas gingivalis in biofilm and gingival cells.
    Sakanaka A; Takeuchi H; Kuboniwa M; Amano A
    Microb Pathog; 2016 May; 94():42-7. PubMed ID: 26456558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Porphyromonas gingivalis mutant defective in a putative glycosyltransferase exhibits defective biosynthesis of the polysaccharide portions of lipopolysaccharide, decreased gingipain activities, strong autoaggregation, and increased biofilm formation.
    Yamaguchi M; Sato K; Yukitake H; Noiri Y; Ebisu S; Nakayama K
    Infect Immun; 2010 Sep; 78(9):3801-12. PubMed ID: 20624909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catecholamines promote the expression of virulence and oxidative stress genes in Porphyromonas gingivalis.
    Graziano TS; Closs P; Poppi T; Franco GC; Cortelli JR; Groppo FC; Cogo K
    J Periodontal Res; 2014 Oct; 49(5):660-9. PubMed ID: 24251763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adhesive protein-mediated cross-talk between Candida albicans and Porphyromonas gingivalis in dual species biofilm protects the anaerobic bacterium in unfavorable oxic environment.
    Bartnicka D; Karkowska-Kuleta J; Zawrotniak M; Satała D; Michalik K; Zielinska G; Bochenska O; Kozik A; Ciaston I; Koziel J; Dutton LC; Nobbs AH; Potempa B; Baster Z; Rajfur Z; Potempa J; Rapala-Kozik M
    Sci Rep; 2019 Mar; 9(1):4376. PubMed ID: 30867500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Porphyromonas gingivalis induces murine macrophage foam cell formation.
    Qi M; Miyakawa H; Kuramitsu HK
    Microb Pathog; 2003 Dec; 35(6):259-67. PubMed ID: 14580389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis.
    Lamont RJ; Jenkinson HF
    Microbiol Mol Biol Rev; 1998 Dec; 62(4):1244-63. PubMed ID: 9841671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Manipulation of Neutrophils by
    Sochalska M; Potempa J
    Front Cell Infect Microbiol; 2017; 7():197. PubMed ID: 28589098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions of oral pathogens with toll-like receptors: possible role in atherosclerosis.
    Hajishengallis G; Sharma A; Russell MW; Genco RJ
    Ann Periodontol; 2002 Dec; 7(1):72-8. PubMed ID: 16013219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PPAD Activity Promotes Outer Membrane Vesicle Biogenesis and Surface Translocation by Porphyromonas gingivalis.
    Vermilyea DM; Moradali MF; Kim HM; Davey ME
    J Bacteriol; 2021 Jan; 203(4):. PubMed ID: 33257525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptide-Based Inhibitors of Fimbrial Biogenesis in Porphyromonas gingivalis.
    Alaei SR; Park JH; Walker SG; Thanassi DG
    Infect Immun; 2019 Mar; 87(3):. PubMed ID: 30642895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parvimonas micra stimulates expression of gingipains from Porphyromonas gingivalis in multi-species communities.
    Neilands J; Davies JR; Bikker FJ; Svensäter G
    Anaerobe; 2019 Feb; 55():54-60. PubMed ID: 30359695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iron and heme utilization in Porphyromonas gingivalis.
    Olczak T; Simpson W; Liu X; Genco CA
    FEMS Microbiol Rev; 2005 Jan; 29(1):119-44. PubMed ID: 15652979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genotyping of Porphyromonas gingivalis in Relationship to Virulence.
    Amano A; Choi YH; Takeuchi H
    Methods Mol Biol; 2021; 2210():53-59. PubMed ID: 32815127
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Muñoz-Medel M; Pinto MP; Goralsky L; Cáceres M; Villarroel-Espíndola F; Manque P; Pinto A; Garcia-Bloj B; de Mayo T; Godoy JA; Garrido M; Retamal IN
    Front Oncol; 2024; 14():1403089. PubMed ID: 38807771
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.